CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 51 filers reported holding CIDARA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $28,000 | -53.3% | 12,326 | -45.3% | 0.00% | – |
| Q1 2021 | $60,000 | +33.3% | 22,516 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | -29.7% | 22,516 | +0.0% | 0.00% | – |
| Q3 2020 | $64,000 | -28.1% | 22,508 | -6.6% | 0.00% | – |
| Q2 2020 | $89,000 | +48.3% | 24,090 | 0.0% | 0.00% | – |
| Q1 2020 | $60,000 | -17.8% | 24,090 | +27.5% | 0.00% | – |
| Q4 2019 | $73,000 | +92.1% | 18,892 | 0.0% | 0.00% | – |
| Q3 2019 | $38,000 | +18.8% | 18,892 | 0.0% | 0.00% | – |
| Q2 2019 | $32,000 | -36.0% | 18,892 | 0.0% | 0.00% | – |
| Q1 2019 | $50,000 | +13.6% | 18,892 | 0.0% | 0.00% | – |
| Q4 2018 | $44,000 | -47.0% | 18,892 | 0.0% | 0.00% | – |
| Q3 2018 | $83,000 | -15.3% | 18,892 | 0.0% | 0.00% | – |
| Q2 2018 | $98,000 | +28.9% | 18,892 | 0.0% | 0.00% | – |
| Q1 2018 | $76,000 | – | 18,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |